The Phase 3 Trial will be presented at SNO in plenary session on November 20th. After that I believe investors should be able to get the details that go beyond TLD which should be issued in late September or beyond.
Gary
(2)
(0)
Northwest Biotherapeutics Inc. (NWBO) Stock Research Links
